English  |  正體中文  |  简体中文  |  2817115  
???header.visitor??? :  27653387    ???header.onlineuser??? :  558
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"hsieh ming yen"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-17 of 17  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-06-22T07:19:55Z Corrigendum: A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii Chen, Sung-Pang; Chen, Eric H-L; Yang, Sheng-Yung; Kuo, Pin-Shin; Jan, Hau-Ming; Yang, Tsai-Chen; Hsieh, Ming-Yen; KUNG-TA LEE; Lin, Chun-Hung; Chen, Rita P-Y
臺大學術典藏 2022-06-22T07:18:13Z A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii Chen, Sung-Pang; Chen, Eric H-L; Yang, Sheng-Yung; Kuo, Pin-Shin; Jan, Hau-Ming; Yang, Tsai-Chen; Hsieh, Ming-Yen; KUNG-TA LEE; Lin, Chun-Hung; Chen, Rita P-Y
嘉南藥理大學 2021 Eradication of hepatitis C virus preserve liver function and prolong survival in advanced hepatocellular carcinoma patients with limited life expectancy Yeh, Ming-Lun; Kuo, Hsing-Tao; Huang, Ching-, I; Huang, Chung-Feng; Hsieh, Ming-Yen; Liang, Po-Cheng; Lin, I-Hung; Hsieh, Meng-Hsuan; Lin, Zu-Yau; Chen, Shinn-Chern; Dai, Chia-Yen; Huang, Jee-Fu; Yu, Ming-Lung; Chuang, Wan-Long
國立交通大學 2020-10-05T02:02:03Z Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection Liang, Po-Cheng; Tsai, Pei-Chien; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Chung, Raymond T.; Yu, Ming-Lung; Tsai, Yi-Shan; Hsieh, Meng-Hsuan; Yeh, Ming-Lun; Huang, Chung-Feng; Huang, Ching-, I; Holmes, Jacinta A.
國立交通大學 2020-10-05T01:59:45Z Cure or curd: Modification of lipid profiles and cardio-cerebrovascular events after hepatitis C virus eradication Huang, Chung-Feng; Dai, Chia-Yen; Yeh, Ming-Lun; Huang, Ching-, I; Lee, Hsiang-Chun; Lai, Wen-Ter; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Chuang, Wan-Long; Yu, Ming-Lung
國立交通大學 2019-12-13T01:09:55Z Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents Jang, Tyng-Yuan; Huang, Ching-, I; Yeh, Ming-Lun; Liang, Po-Cheng; Tsai, Pei-Chien; Lin, Yi-Hung; Hsieh, Ming-Yen; Hou, Nai-Jen; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung
國立交通大學 2019-12-13T01:09:55Z Ribavirin facilitates early viral kinetics in chronic hepatitis C patients receiving daclatasvir/asunaprevir Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-, I; Liang, Po-Cheng; Lin, Yi-Hun; Hsieh, Ming-Yen; Chen, Kuan-Yu; Ko, Yu-Min; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung
國立交通大學 2019-08-02T02:18:29Z Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort study Huang, Chung-Feng; Yeh, Ming-Lun; Huang, Ching-I; Liang, Po-Cheng; Lin, Yi-Hung; Hsieh, Ming-Yen; Wei, Yu-Ju; Lin, Zu-Yau; Chen, Shinn-Cherng; Huang, Jee-Fu; Dai, Chia-Yen; Chuang, Wan-Long; Yu, Ming-Lung
嘉南藥理大學 2016-04 Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol Wu, Kuan-Ta; Kuo, Po-Lin; Su, Shih-Bin; Chen, Yi-Yu; Yeh, Ming-Lum; Huang, Ching-I; Yang, Jeng-Fu; Lin, Chia-I; Hsieh, Meng-Hsuan; Hsieh, Ming-Yen; Huang, Chung-Feng; Lin, Wen-Yi; Yu, Ming-Lung; Dai, Chia-Yen; Wang, Hsien-Yi
國立交通大學 2014-12-12T01:51:00Z 太陽能併網整合及逆變器系統之產業研究 謝明諺; Hsieh, Ming-Yen; 徐作聖
高雄醫學大學 2013 非肝癌癌症C型肝炎患者接受長效型干擾素合併雷巴威靈治療之療效與安全性多中心研究  黃釧峰;黃志富;陳武政;葉明倫;黃駿逸;楊正福;莊萬龍;戴嘉言;謝明彥;林子堯;陳信成;余明隆; Huang, Chung-Feng;Huang, Jee-Fu;Chen, Wu-Cheng;Yeh, Ming-Lun;Huang, Ching-I;Yang, Jeng-Fu;Chuang, Wan-Long;Dai, Chia-Yen;Hsieh, Ming-Yen;Lin, Zu-Yau;Chen, Shinn-Cherng;Yu, Ming-Lung
嘉南藥理大學 2012-05 Erratum to:"Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin"[J Hepatol 2012;56:34–40] Huang, Chung-Feng; Huan, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung
嘉南藥理大學 2012 Interleukin-28B genetic variants in identification of hepatitis C virus genotype 1 patients responding to 24 weeks peginterferon/ribavirin Huang, Chung-Feng; Huang, Jee-Fu; Yang, Jeng-Fu; Hsieh, Ming-Yen; Lin, Zu-Yau; Chen, Shinn-Cherng; Wang, Liang-Yen; Juo, Suh-Hang Hank; Chen, Ku-Chung; Chuang, Wan-Long; Kuo, Hsing-Tao; Dai, Chia-Yen; Yu, Ming-Lung
國立成功大學 2010-07-08 以靜態分析實現惡意程式行為分析器 謝銘晏; Hsieh, Ming-Yen
東海大學 2008 列車站間差別訂價與折扣模式之應用-以台灣高鐵為例 謝明燕; Hsieh, Ming-Yen
高雄醫學大學 2007 慢性C型肝炎患者抗核抗體(ANA)陽性率對臨床表徵及對干擾素合併ribavirin治療療效之影響 謝明彥; Hsieh, Ming-Yen
高雄醫學大學 2007 慢性C型肝炎患者抗核抗體(ANA)陽性率對臨床表徵及對干擾素合併ribavirin治療療效之影響 謝明彥; Hsieh, Ming-Yen

Showing items 1-17 of 17  (1 Page(s) Totally)
1 
View [10|25|50] records per page